HIV / AIDS

John Koethe, MD, of Vanderbilt University Medical Center, reacts to current trends in new HIV diagnoses among various patient populations.

Pharmacist-initiated access, as well as longer treatment durations, may redefine HIV prevention efforts.

Reviewers attribute less severe COVID-19 symptoms in patients with HIV and low CD4 count to reduced capacity for immune reactions including cytokine storm.

Three HIV screening strategies identified comparable numbers of new HIV diagnoses, a new study found.

Patients given a 600 mg injection of cabotegravir still had detectable levels of the drug in plasma, tissues, and fluids for 12 weeks.

A recent study of sexually active young women in Africa found that initiation of HIV preexposure prophylaxis (PrEP) was high at 95% and one-fifth showed high adherence at 6 months.

A discussion as to why people with unstable housing living with HIV may not prefer telehealth versus consistent in-person care.

The risk of COVID-19 severity in people living with HIV may be less than previously anticipated.

Due to limited familiarity with providing antiretroviral medication, many participants were hesitant to initiate PrEP.

Investigators wanted to study usage of F/TAF vs F/TDF in clinical practice and HIV seroconversion.

Adherence for daily dosing decreased and event-driven PrEP usage increased in a Chinese study.

Impaired resilience was found to be associated with loneliness.

Virtual support services were crucial for providing continued care and education.

In a pilot project, customers were surveyed about HIV risk behaviors to gain further insights and assessed for potential PrEP utilization.

New 24-week findings from Merck highlight the potential of a 1-month PrEP option for low-risk patients.

Many respondents reported having a lack of information about the use of PrEP.

PLWH should strictly maintain ART therapy and COVID-19 mitigation efforts.

Crowdsourcing and other approaches may develop more effective interventions to promote PS.

More tailored strategies could improve PrEP provision in family planning clinics.

A meta-analysis study found that 70% of PrEP users either stopped or had inadequate adherence within 6 months of initiation.

Small survey from gay and bisexual men (GBM) inquired about their experiences during COVID-19 restrictions, and feedback on PrEP.

No significant difference was observed across the 3 study groups.

A positive relationship may exist between infection severity and adaptive immunity.

In Brazil, a concerted effort of recruiting adolescents was made to go out and talk with them about PrEP.

Rates of testing for HIV, as well as PrEP uptake, remain suboptimal in MSM of color.

US residents with HIV have higher rates of mortality than their peers without infection, but the gap is narrowing, a recent study showed.

Investigators surveyed men who have sex with men (MSM) about long-acting injectable pre-exposure prophylaxis (PrEP) including attitudes towards potentially taking it and barriers to usage.

The pandemic's effect on in-person care prioritization may have indirectly influenced the rate of screening opportunities in at-risk persons.

New findings from CUSTOMIZE suggest the once-monthly injection therapy was feasibly implemented and generally favored to once-daily tablets.

Perspective gained from persons treated a real-world clinic may help better inform strategies to treat an HIV population that often struggles with viral suppression and consistent care.